Iridex IRIX
NASDAQ IRIX
$0.76 -0.01 (-0.72%)
At close: Aug 21, 2026 · 4:00 PM EDT

Iridex (IRIX) Net Equity Issued and Repurchased (2017 - 2022)

Iridex (IRIX) posted quarterly Net Equity Issued and Repurchased of -$9.9 million for Q4 2022, down 200.0% quarter-over-quarter from $9.9 million in Q2 2021.

Iridex (IRIX) Net Equity Issued and Repurchased (2017 - 2022) Analysis & Trends

Iridex's Net Equity Issued and Repurchased history runs 4 years deep, the most recent figure standing at -$9.9 million for Q4 2022.

  • In Q4 2022, Net Equity Issued and Repurchased changed N/A year-over-year to -$9.9 million; the TTM figure through Sep 2025 stood at -$9.9 million (changed 0.0% YoY), while the FY2026 annual figure was $6.0 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased for Q4 2022 stood at -$9.9 million, down from $9.9 million in the prior quarter.
  • The five-year high for Net Equity Issued and Repurchased was $9.9 million in Q2 2021, with the low at -$9.9 million in Q4 2022.
  • The 3-year median for Net Equity Issued and Repurchased is -$162000.0 (2018), against an average of -$54000.0.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn -
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn 97.00 Mn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn -
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn -
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn -
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn -
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn -
10 Iridex 13.09 Mn 8.41 Mn 4.30 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 -9.88 Mn
Dec 31, 2022 -9.88 Mn
Apr 3, 2021 9.88 Mn
Apr 3, 2021 9.88 Mn
Dec 29, 2018 -162,000.00
Dec 29, 2018 -162,000.00
Apr 1, 2017 2.26 Mn
Apr 1, 2017 2.26 Mn